Delivery Order SPE2DB22D1017-SPE2DB25FYNZD
Award Date 8/25/25
Potential Completion Date 8/26/25
Potential Value $12K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $7,181.52 for 60 tablets of MULTAQ 400 mg on August 6, 2025, with completion scheduled for August 7, 2025. This firm fixed-price, non-set-aside contract represents a single delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The delivery order will be performed at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for MULTAQ 400 mg tablets (60-count packaging) valued at $1,481.13, with a firm fixed price structure. This award, issued on November 25, 2025, represents a non-competitive delivery order with an ultimate completion date of November 26, 2025. The contract is performed out of AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, reflecting the company's role as a major pharmaceutical distributor...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,481.13 to AmerisourceBergen Drug Corp for MULTAQ 400 mg tablets (60-count units) on November 3, 2025, with an ultimate completion date of November 4, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. MULTAQ is a prescription antiarrhythmic medication used in the treatment...
- The Defense Logistics Agency awarded a delivery order valued at $11,072.34 to AmerisourceBergen Drug Corp for the supply of MULTAQ 400 mg tablets (60 count) on August 26, 2025, with an ultimate completion date of August 27, 2025. This is a firm fixed price contract with no set-aside designation, performed at the contractor's corporate office location in Conshohocken, Pennsylvania. MULTAQ is a prescription antiarrhythmic medication used to reduce the risk of cardiovascular hospitalization in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 28, 2025, for the supply of MULTAQ 400 mg tablets (60-count units) under a firm fixed-price contract valued at $14,543.02. This non-set-aside award was issued competitively and is scheduled for completion by April 29, 2025. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania. This delivery order represents a routine pharmaceutical procurement supporting the federal...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for 60 tablets of Multaq 400 mg at a firm fixed price of $21,111.48, with completion scheduled by September 30, 2025. This competitively awarded, non-set-aside contract represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The prime...
- The Defense Logistics Agency awarded a $4,031.84 delivery order to AmerisourceBergen Drug Corp for MULTAQ 400 mg tablets (60-count units) on September 2, 2025, with an ultimate completion date of September 3, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. MULTAQ is an antiarrhythmic medication used in the treatment of atrial fibrillation,...
- The Defense Logistics Agency awarded a $11,294.22 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Multaq 400 mg on December 4, 2025, with completion scheduled for December 5, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $6,028.44 to AmerisourceBergen Drug Corp for MULTAQ 400 MG tablets (60-count packages) on November 28, 2025, with a completion date of December 1, 2025. This is a firm fixed-price delivery order with no set-aside designation, utilizing competitive procurement procedures. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a $45,743.81 delivery order to AmerisourceBergen Drug Corp for 60 tablets of MULTAQ 400 mg, a pharmaceutical product used in cardiac arrhythmia management. Issued on October 20, 2025, with a completion date of October 21, 2025, this firm fixed-price contract represents a competitive award with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...